Paying users zone. Data is covered by .

  • Get to Bristol-Myers Squibb Co. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

 

$15.99


Ratios (Summary)

Bristol-Myers Squibb Co., debt and solvency ratios

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Debt to equity
Debt to capital
Interest coverage

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

Ratio Description The company
Debt-to-equity ratio A solvency ratio calculated as total debt divided by total shareholders' equity. Bristol-Myers Squibb Co.'s debt-to-equity ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
Debt-to-capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. Bristol-Myers Squibb Co.'s debt-to-capital ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Bristol-Myers Squibb Co.'s interest coverage ratio improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017.

Top


Debt to Equity

Bristol-Myers Squibb Co., debt to equity calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Short-term debt obligations
Long-term debt, excluding current portion
Total debt
Total Bristol-Myers Squibb Company shareholders' equity
Ratio
Debt to equity1
Benchmarks
Debt to Equity, Competitors
Abbott Laboratories
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Debt to Equity, Sector
Pharmaceuticals & Biotechnology
Debt to Equity, Industry
Health Care

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Debt to equity = Total debt ÷ Total Bristol-Myers Squibb Company shareholders' equity
= ÷ =

Ratio Description The company
Debt-to-equity ratio A solvency ratio calculated as total debt divided by total shareholders' equity. Bristol-Myers Squibb Co.'s debt-to-equity ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Debt to Capital

Bristol-Myers Squibb Co., debt to capital calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Short-term debt obligations
Long-term debt, excluding current portion
Total debt
Total Bristol-Myers Squibb Company shareholders' equity
Total capital
Ratio
Debt to capital1
Benchmarks
Debt to Capital, Competitors
Abbott Laboratories
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Debt to Capital, Sector
Pharmaceuticals & Biotechnology
Debt to Capital, Industry
Health Care

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Debt to capital = Total debt ÷ Total capital
= ÷ =

Ratio Description The company
Debt-to-capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. Bristol-Myers Squibb Co.'s debt-to-capital ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Interest Coverage

Bristol-Myers Squibb Co., interest coverage calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net earnings attributable to BMS
Add: Net income attributable to noncontrolling interest
Add: Income tax expense
Add: Interest expense
Earnings before interest and tax (EBIT)
Ratio
Interest coverage1
Benchmarks
Interest Coverage, Competitors
Abbott Laboratories
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Interest Coverage, Sector
Pharmaceuticals & Biotechnology
Interest Coverage, Industry
Health Care

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Interest coverage = EBIT ÷ Interest expense
= ÷ =

Ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Bristol-Myers Squibb Co.'s interest coverage ratio improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017.

Top